Skip to main content
. Author manuscript; available in PMC: 2009 Feb 26.
Published in final edited form as: Biotechnol Bioeng. 2005 May 5;90(3):290–302. doi: 10.1002/bit.20393

Figure 7.

Figure 7

Cellular viability. The MTS assay was used to determine cellular viability on serum-modified substrate. The MTS assay was also used to determine cellular viability after delivery of complexes from FBS-PS and PS substrates and through bolus delivery. Data are presented as average ± standard deviation of the mean. *P < 0.05 relative to cellular viability on PS (control).